Patents
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
07/2011
07/12/2011CA2503451C Heterocyclic compounds and antitumor agent comprising the same as effective component
07/12/2011CA2461202C Lactam-containing compounds and derivatives thereof as factor xa inhibitors
07/12/2011CA2422617C Tripeptidyl peptidase inhibitors
07/12/2011CA2389685C Novel heterocyclic compounds and their use as medicaments
07/07/2011WO2011082077A1 Hepatitis c virus inhibitors
07/07/2011WO2011081205A1 1,3,4-oxadiazole-2-carboxamide compound
07/07/2011WO2011080718A1 Inhibitors of diacylglycerol acyl transferase
07/07/2011WO2011080568A2 Novel pyrimidine compounds as mtor and p13k inhibitors
07/07/2011WO2011080341A1 Process for the preparation of rivaroxaban and intermediates thereof
07/07/2011WO2011080313A1 Novel piperine derivatives as gaba - a receptors modulators
07/07/2011WO2011080266A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives.
07/07/2011WO2011080265A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
07/07/2011US20110166358 Nitrogen-containing heterocyclic compound and pest control agent
07/07/2011US20110166347 Process for preparation of mycophenolic acid, its salt and ester derivatives
07/07/2011US20110166346 Novel napthalimide-benzimidazole hybrids as potential antitumor agents and process for the preparation thereof
07/07/2011US20110166343 Thienopyrazole derivative having pde7 inhibitory activity
07/07/2011US20110166193 Insecticidal compounds
07/07/2011US20110166184 Insecticidal compounds
07/07/2011US20110166169 Novel hsp90 inhibitory carbazole derivatives, compositions containing same and use thereof
07/07/2011US20110166156 Prodrugs for the Treatment of Schizophrenia and Bipolar Disease
07/07/2011US20110166155 Substituted Isoindolones and Their Use as Metabotropic Glutamate Receptor Potentiators
07/07/2011US20110166139 Pyridine compounds
07/07/2011US20110166138 Inhibitors of Fatty Acid Amide Hydrolase and Monoacylglycerol Lipase for Modulation of Cannabinoid Receptors
07/07/2011US20110166137 Substituted Naphthalenyl-Pyrimidine Compounds
07/07/2011US20110166136 Calcium Ion Channel Modulators & Uses Thereof
07/07/2011US20110166135 Aromatic nitrogen-containing 6-membered ring compounds and their use
07/07/2011US20110166132 Gamma Secretase Modulators
07/07/2011US20110166130 Novel potassium channel blockers and uses thereof
07/07/2011US20110166125 Substituted amides, manufacturing and use thereof as medicaments
07/07/2011US20110166120 Sulfonyl amide derivatives for the treatment of abnormal cell growth
07/07/2011US20110166117 Novel Compounds
07/07/2011US20110166116 New compounds, pharmaceutical composition and methods relating thereto
07/07/2011US20110166088 Benzothiazoles and aza-analogues thereof use as antibacterial agents
07/07/2011US20110166082 Antisense composition and method for treating muscle atrophy
07/07/2011US20110165225 Modified Drugs for Use in Liposomal Nanoparticles
07/07/2011US20110165188 N-hydroxyamidinoheterocycles as modulators of indoleamine 2,3-dioxygenase
07/07/2011US20110165120 Inhibitors of serine proteases
07/07/2011CA2788450A1 Substituted naphthalenyl-pyrimidine compounds
07/07/2011CA2785679A1 1,3,4-oxadiazole-2-carboxamide compound
07/07/2011CA2785618A1 Pyrimidine compounds as mtor and pi3k inhibitors
07/07/2011CA2783230A1 New secondary 8-hydroxyquinoline-7-carboxamide derivatives
07/07/2011CA2783216A1 Secondary 8-hydroxyquinoline-7-carboxamide derivatives for use as antifungal agents
07/06/2011EP2340830A2 Hepatitis C Virus Inhibitors
07/06/2011EP2340249A1 Poly-heteroaryl derivatives for the treatment of cancer
07/06/2011EP2340244A1 Compounds and methods of use
07/06/2011EP2340243A1 Heteroaryl substituted indole compounds useful as mmp-13 inhibitors
07/06/2011EP2340021A1 Substituted pyrrolidine-2-carboxamides
07/06/2011EP2339919A1 Bicyclic dihydroimidazolone cgrp receptor antagonists
07/06/2011EP2152370B1 Aryl ether pyridazinone derivatives
07/06/2011EP2066663B1 Heterocyclic fxr binding compounds
07/06/2011EP1588145B1 Methods, mixtures, kits and compositions pertaining to analyte determination
07/06/2011EP1492765B1 Novel gamma secretase inhibitors
07/06/2011CN102119160A Cyclic inhibitors of 11 beta-hydroxysteroid dehydrogenase 1
07/06/2011CN102119157A Tricyclic 2,4-diamino-L,3,5-triazine derivatives useful for the treatment of cancer and myeloproliferative disorders
07/06/2011CN102119154A Polymerizable benzoxazine compositions
07/06/2011CN102119152A Organic compounds
07/06/2011CN102119047A Heteroaryl derivatives as DGAT1 inhibitors
07/06/2011CN102115610A Fluorescent dye, preparation method and application thereof
07/06/2011CN101381365B Dual action antibiotics
07/06/2011CN101151262B Substituted piperidines
07/06/2011CN101014572B Carbamoylpyridone derivative having HIV integrase inhibitory activity
07/05/2011US7973170 N3 alkylated benzimidazole derivatives as MEK inhibitors
07/05/2011US7973160 Nitrogen-containing aromatic derivatives
07/05/2011US7973065 Antimicrobial compounds
07/05/2011US7973061 Anaplastic lymphoma kinase modulators and methods of use
07/05/2011US7973057 Thalidomide analogs
07/05/2011US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4
07/05/2011US7973041 Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases
07/05/2011CA2630269C Inhibitors of diacyglycerol acyltransferase (dgat)
07/05/2011CA2564563C Indolyl derivatives as liver-x-receptor modulators
07/05/2011CA2549062C Novel oxazolidinone derivatives
07/05/2011CA2535711C Caspase inhibitors containing isoxazoline ring
07/05/2011CA2506242C 4-tetrazolyl-4phenylpiperidine derivatives for treating pain
07/05/2011CA2486090C Pyridine carboxamide derivatives and their use as pesticides
07/05/2011CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
07/05/2011CA2475867C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors
07/05/2011CA2423279C Phthalazinone derivatives
07/05/2011CA2217745C Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease
06/2011
06/30/2011WO2011079102A1 Indolyl-piperidinyl benzylamines as beta-tryptase inhibitors
06/30/2011WO2011079034A1 Extracts from kibdelos porangium as antibacterial agents
06/30/2011WO2011079007A1 Crth2 modulators
06/30/2011WO2011078413A1 Seven-membered ring compound and pharmaceutical use therefor
06/30/2011WO2011078369A1 Novel aryl urea derivative
06/30/2011WO2011078360A1 Amide compound
06/30/2011WO2011078143A1 Pyrimidine derivatives and pharmaceutical composition containing same
06/30/2011WO2011077726A1 4-amino-1,3-thiazine or oxazine derivative
06/30/2011WO2011077712A1 Novel 1-(biphenyl-4-yl-methyl)-1h-imidazole derivative and pharmaceutical product containing same
06/30/2011WO2011077711A1 Novel 2-pyridone derivative and pharmaceutical product containing same
06/30/2011WO2011077313A1 Piperidinecarboxamides as mpges - 1 inhibitors
06/30/2011WO2011077226A1 Procedure for the synthesis of fluorescent probes for metals
06/30/2011WO2011076930A1 Cyclic hydroxylamine derivatives, their preparation and use as antioxidants
06/30/2011WO2011076786A1 Substituted isoquinolinones and quinazolinones
06/30/2011WO2011076678A1 Substituted benzamide derivatives
06/30/2011WO2011076510A1 Pyrazole derivatives
06/30/2011WO2011048148A3 Glycoside derivative and uses thereof
06/30/2011WO2011017350A3 Compounds as lysophosphatidic acid receptor antagonists
06/30/2011WO2010132999A8 Methyl sulfanyl pyrmidmes useful as antiinflammatories, analgesics, and antiepileptics
06/30/2011WO2010110685A4 Pyrimidinyl and 1,3,5-triazinyl benzimidazole sulfonamides and their use in cancer therapy
06/30/2011US20110160255 Inhibitors of akt activity
06/30/2011US20110160210 Control of intraocular pressure using alk5 modulation agents